| HOME >> BIOLOGY >> TECHNOLOGY |
these non-GAAP measures should not be relied upon independently as they
ignore the contribution to our operating results that is generated by the
incentive and compensation effects of the underlying stock-based
compensation programs.
Cynosure's management believes that these non-GAAP financial measures
provide meaningful supplemental information regarding our performance by
excluding certain expenses and expenditures that may not be indicative of
our core business operating results. Cynosure believes that both
management and investors benefit from referring to these non-GAAP
financial measures in assessing Cynosure's performance and when planning,
forecasting and analyzing future periods. These non-GAAP financial
measures also facilitate management's internal comparisons to Cynosure's
historical performance and our competitors' operating results. Cynosure
believes that these non-GAAP measures are useful to investors in allowing
for greater transparency with respect to supplemental information used by
management in its financial and operational decision making.
Reconciliation of GAAP Income Statement Measures to Non-GAAP Income
Statement Measures
(In thousands, except per share data)
Three Months Ended March 31,
2008 2007
(unaudited)
Gross profit $24,392 $16,155
Non-GAAP adjustments to gross profit:
Stock-based compensation 129 98
Total Non-GAAP adjustments to gross profit 129 98
Non-GAAP Gross profit $24,521 $16,253
'/>"/>
| SOURCE Cynosure, Inc. Copyright©2008 PR Newswire. All rights reserved |